Texas Instruments (TXN) Q3 2026 Earnings Call Transcript

Texas Instruments reported third-quarter revenue of $6.06 billion, up 28% year over year, and EPS of $2.62, up 77%; industrial revenue rose more than 40% to a record, while data-center revenue grew about 95% and reached 13% of sales. Management forecast fourth-quarter revenue of $5.80 billion to $6.30 billion and EPS of $2.45 to $2.79, citing above-seasonal demand. The company raised its dividend 7% to $1.52 per share, while noting slightly longer lead times, particularly for back-end tools.

Analysis

The key read-through is not simply stronger end demand: tight foundational-chip supply is giving Texas Instruments more pricing leverage while its factories ramp. If that leverage persists, pricing and richer mix can support margins beyond the cyclical volume rebound. But the quarter’s roughly 90% incremental gross margin should not be annualized; management’s longer-run framework is lower, and tooling delays—particularly in back-end assembly and test—could make capacity, rather than demand, the near-term limiter.

Near term, above-seasonal guidance reduces the usual Q4 seasonal headwind, but the wide range leaves room for shipment timing and product mix to disappoint. Over the next 1–3 months, the important catalyst is whether annual customer negotiations translate into durable 2027 pricing, not merely urgent orders. Over 6–18 months, internal capacity and foundry-to-internal transitions may improve control and margins, but require execution and capital before the benefit is fully realized. Data-center demand is a meaningful tailwind, yet TI sells broad building-block content; do not value it as a direct proxy for compute spending. Industrial strength also combines structural content gains with cyclical recovery, so a new peak alone does not establish a higher growth floor.

Contrarian risk: the market may extrapolate peak-cycle operating leverage while overlooking elevated inventory days, tool availability, and the fact that trailing free cash flow includes substantial CHIPS Act support. Treat humanoid-robotics content as optionality, not a near-term earnings driver. No independent evidence here establishes competitor share losses or a durable pricing step-change.

Key Decisions for Investors

• Consider a measured long TXN on post-earnings weakness rather than chasing the print. The thesis is pricing power plus an improving internal manufacturing mix; size against the possibility that margins normalize toward management’s longer-run framework.
• Use the January pricing update and next guidance as the 1–3 month confirmation point: look for evidence that 2027 pricing is broad-based and that lead times and back-end tool constraints are not limiting shipments. If pricing remains isolated to urgent analog supply, do not underwrite a structural margin reset.
• Keep an alert on quarterly inventory days, cash conversion excluding CHIPS Act incentives, and CapEx/tool deliveries. A renewed inventory build alongside weaker orders, or capacity delays that constrain revenue, would weaken the long thesis.
• Do not add a dedicated data-center or robotics premium to TXN estimates yet. Reassess only with sustained customer demand and evidence that new sockets are converting into repeatable revenue; a slowdown in data-center investment is a key downside catalyst.